Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Okta Stock Is Rising Today

TheMotleyFool

0 0

Shares of Okta (NASDAQ: OKTA) were climbing today after health officials in the U.S. recommended that use of the Johnson & Johnson coronavirus vaccine be paused until more information about potential blood clots can be assessed.

The tech stock was up 6% as of 1:57 p.m. EDT.

Both the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention recommended that the Johnson & Johnson vaccine not be used right now "out of an abundance of caution." The agencies are reviewing "six reported U.S. cases of a rare and severe type of blood clot" that occurred in those individuals after taking the vaccine. To date, 6.8 million doses of the Johnson & Johnson vaccine have been administered.

Source Fool.com

Like: 0

OKTA

Share